To those new to RGBP, a couple questions you need to answer before you lay your money down.
1. What is my timeframe/goal
2. What is the impetus I think will drive the price.
Don't believe the postings on this board of "to the moon", comparisons to other stocks that went up etc.
As one who has lost tens of thousands in the past on RGBP believing the hype, do your homework and learn from history.
- 1. RGBP is the not original company. The company (run by David Koos that developed HemaXellerate and DCELL etc. was BMSN (Bio-Matrix) which went to triple 000s in spite of successfully developing an IND to approval to clinical trials. No trials took place after approval. Koos created RGBP with a lower share count (at that time) to raise money and transferred the patents regarding to RGBP for the NR2F6 by an in house scientist that had dedicated her life to research because of losing her mother to cancer. Koos bought her science and issued some agreements to her for future success and then at some point, never released via PR, she is no longer employed by the company. The company at this point, with Todd Cavens leaving, is only David Koos.
2. RGBP and RGBPP went north of .50 on the expectations of NR2F6 and agreements for research with NIH.
3. As RGBP went to low pennies and then sub-pennies, Koos took RGBP's main reason of existence - NR2F6 and spun it off (licensed) to a new company he created KCL and some to Zander Therapeutics (which he also created)?
Why the need for more and more companies you should ask, especially when David Koos and maybe one other person is in charge of each? You'd have to ask him, but the obvious is selling new shares to raise money because he pays himself a salary each year upwards of 400K and if you can track down and add up all the self imposed salaries and shares of all the one man companies, who knows what it amounts to.
Did he get a good deal with ONPH - sure, 1.5M in shares with future potential royalties is a personal goldmine for him as he has gone for years just giving himself shares and selling them to live on, all while the books pile up more debt.
But that 1.5M is going to quickly absorbed when the financials come out as he will use it to pay himself off.
There is no reason that Koos filing financials is going to be reason for RGBP to "skyrocket". It will only show millions in debt.
So if you are going to invest, I hope you are a DT playing a quick in/out or a multi-year investor banking on income from ONPH. But if that is your plan, much better to invest directly in ONPH as they will reap 90-95% of income from NR2F6, while the 5%-10% to RGBP will pay for Koos' ongoing lifestyle.
